Paul Knight
Stock Analyst at KeyBanc
(3.52)
# 2,268
Out of 5,076 analysts
253
Total ratings
44.6%
Success rate
4.7%
Average return
Main Sectors:
Stocks Rated by Paul Knight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVTY Revvity | Reiterated: Buy | $125 → $165 | $157.36 | +4.86% | 13 | Sep 4, 2026 | |
| LFCR Lifecore Biomedical | Reiterated: Hold | n/a | $6.37 | - | 4 | Aug 6, 2026 | |
| TKNO Alpha Teknova | Reiterated: Hold | n/a | $6.15 | - | 5 | Aug 6, 2026 | |
| WST West Pharmaceutical Services | Reiterated: Buy | $350 → $390 | $394.03 | -1.02% | 16 | Jul 2, 2026 | |
| CSTL Castle Biosciences | Reiterated: Buy | $50 → $35 | $33.15 | +5.58% | 9 | May 29, 2026 | |
| RPID Rapid Micro Biosystems | Reiterated: Buy | $8 → $5 | $0.801 | +524.22% | 3 | May 29, 2026 | |
| CYRX Cryoport | Reiterated: Buy | $15 → $17 | $17.83 | -4.66% | 10 | May 20, 2026 | |
| TECH Bio-Techne | Reiterated: Hold | n/a | $72.62 | - | 19 | May 7, 2026 | |
| XGN Exagen | Reiterated: Buy | $15 → $10 | $7.48 | +33.69% | 11 | Mar 11, 2026 | |
| STVN Stevanato Group | Rated: Buy | $37 → $32 | $19.50 | +64.10% | 7 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.6356 | - | 9 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $220 | $178.71 | +23.10% | 13 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $310 | $229.75 | +34.93% | 9 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $750 | $676.54 | +10.86% | 9 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €415.00 → €320.00 | €273.50 | n/a | 2 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $220 | $128.10 | n/a | 2 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | CHF 525.00 | CHF 387.40 | n/a | 1 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $173.89 | n/a | 12 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $460 | $455.59 | n/a | 9 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $30 | $17.15 | n/a | 3 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $7 → $30 | $8.34 | n/a | 9 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $32.00 | n/a | 2 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $129.10 | n/a | 3 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 610.00 → CHF 635.00 | CHF 628.20 | n/a | 6 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.07 | n/a | 9 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $36.01 | n/a | 9 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $300 | $339.66 | n/a | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $250 | $278.32 | n/a | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.84 | n/a | 6 | Mar 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 → $30 | $16.39 | n/a | 3 | Feb 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 → $2 | $0.0006 | n/a | 8 | Nov 26, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.76 | n/a | 2 | Jul 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $46.04 | n/a | 7 | Nov 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $269.40 | n/a | 6 | Oct 23, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $57.31 | n/a | 4 | Mar 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.928 | n/a | 2 | Mar 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $69.16 | n/a | 1 | Feb 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $75 → $85 | $226.88 | n/a | 2 | Jul 24, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $1.38 | n/a | 1 | May 5, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $61 → $46 | $11.98 | n/a | 2 | Dec 19, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $255 | $1,684.64 | n/a | 1 | Aug 15, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $24 | $50.22 | n/a | 1 | Aug 15, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $18 | $0.50 | n/a | 1 | Aug 15, 2013 |
Revvity
Sep 4, 2026
Reiterated: Buy
Price Target: $125 → $165
Current: $157.36
Upside: +4.86%
Lifecore Biomedical
Aug 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $6.37
Upside: -
Alpha Teknova
Aug 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $6.15
Upside: -
West Pharmaceutical Services
Jul 2, 2026
Reiterated: Buy
Price Target: $350 → $390
Current: $394.03
Upside: -1.02%
Castle Biosciences
May 29, 2026
Reiterated: Buy
Price Target: $50 → $35
Current: $33.15
Upside: +5.58%
Rapid Micro Biosystems
May 29, 2026
Reiterated: Buy
Price Target: $8 → $5
Current: $0.801
Upside: +524.22%
Cryoport
May 20, 2026
Reiterated: Buy
Price Target: $15 → $17
Current: $17.83
Upside: -4.66%
Bio-Techne
May 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $72.62
Upside: -
Exagen
Mar 11, 2026
Reiterated: Buy
Price Target: $15 → $10
Current: $7.48
Upside: +33.69%
Stevanato Group
Mar 5, 2026
Rated: Buy
Price Target: $37 → $32
Current: $19.50
Upside: +64.10%
Feb 25, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.6356
Upside: -
Feb 25, 2026
Reiterated: Buy
Price Target: $220
Current: $178.71
Upside: +23.10%
Dec 18, 2025
Rated: Buy
Price Target: $310
Current: $229.75
Upside: +34.93%
Dec 8, 2025
Upgraded: Buy
Price Target: $750
Current: $676.54
Upside: +10.86%
Oct 7, 2025
Reiterated: Buy
Price Target: €415.00 → €320.00
Current: €273.50
Upside: n/a
Sep 10, 2025
Reiterated: Buy
Price Target: $220
Current: $128.10
Upside: n/a
Sep 4, 2025
Initiated Coverage: Buy
Price Target: CHF 525.00
Current: CHF 387.40
Upside: n/a
Aug 28, 2025
Reiterated: Hold
Price Target: n/a
Current: $173.89
Upside: n/a
Aug 18, 2025
Reiterated: Buy
Price Target: $460
Current: $455.59
Upside: n/a
Jun 3, 2025
Reiterated: Buy
Price Target: $40 → $30
Current: $17.15
Upside: n/a
Apr 9, 2025
Downgraded: Hold
Price Target: $7 → $30
Current: $8.34
Upside: n/a
Mar 31, 2025
Downgraded: Hold
Price Target: n/a
Current: $32.00
Upside: n/a
Feb 5, 2025
Reiterated: Hold
Price Target: n/a
Current: $129.10
Upside: n/a
Jan 30, 2025
Reiterated: Buy
Price Target: CHF 610.00 → CHF 635.00
Current: CHF 628.20
Upside: n/a
May 9, 2024
Rated: Hold
Price Target: n/a
Current: $7.07
Upside: n/a
Nov 14, 2023
Rated: Hold
Price Target: n/a
Current: $36.01
Upside: n/a
May 5, 2022
Reiterated: Buy
Price Target: $300
Current: $339.66
Upside: n/a
Apr 28, 2022
Reiterated: Buy
Price Target: $250
Current: $278.32
Upside: n/a
Mar 14, 2022
Downgraded: Hold
Price Target: n/a
Current: $2.84
Upside: n/a
Feb 27, 2020
Reiterated: Hold
Price Target: $20 → $30
Current: $16.39
Upside: n/a
Nov 26, 2019
Downgraded: Hold
Price Target: $6 → $2
Current: $0.0006
Upside: n/a
Jul 24, 2019
Downgraded: Hold
Price Target: n/a
Current: $4.76
Upside: n/a
Nov 29, 2018
Downgraded: Hold
Price Target: n/a
Current: $46.04
Upside: n/a
Oct 23, 2017
Upgraded: Hold
Price Target: n/a
Current: $269.40
Upside: n/a
Mar 27, 2017
Downgraded: Hold
Price Target: n/a
Current: $57.31
Upside: n/a
Mar 11, 2016
Downgraded: Hold
Price Target: n/a
Current: $0.928
Upside: n/a
Feb 10, 2016
Initiated Coverage: Buy
Price Target: n/a
Current: $69.16
Upside: n/a
Jul 24, 2014
Downgraded: Hold
Price Target: $75 → $85
Current: $226.88
Upside: n/a
May 5, 2014
Upgraded: Buy
Price Target: n/a
Current: $1.38
Upside: n/a
Dec 19, 2013
Rated: Hold
Price Target: $61 → $46
Current: $11.98
Upside: n/a
Aug 15, 2013
Initiated Coverage: Hold
Price Target: $255
Current: $1,684.64
Upside: n/a
Aug 15, 2013
Initiated Coverage: Hold
Price Target: $24
Current: $50.22
Upside: n/a
Aug 15, 2013
Initiated Coverage: Hold
Price Target: $18
Current: $0.50
Upside: n/a